Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting

International Journal of Cardiology

Volumn 139, Issue 2, 2010, Pages 134-141

  Scheubel, Robert J ^a   Holtz, Juergen ^a   Friedrich, Ivar ^a   Borgermann, Jochen ^a   Kahrstedt, Simone ^a   Navarrete Santos, Alexander ^a   Silber, Rolf Edgar ^a   Simm, Andreas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Angiogenesis; Cytokines; Hypoxia; Paracrine mechanisms; Stem cells

Indexed keywords

ANGIOGENIN; CXCL9 CHEMOKINE; EOTAXIN; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CD34 PROGENITOR CELL; CELL CULTURE; CELL SIZE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL; HYPOXIA; OXYGEN CONCENTRATION; PARACRINE SIGNALING; PRIORITY JOURNAL; SPHEROID CELL; STEM CELL;

ANTIGENS, CD34; CELL COMMUNICATION; CELL HYPOXIA; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-6; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; SPHEROIDS, CELLULAR; UMBILICAL VEINS;

EID: 77249156220     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.009     Document Type: Article

References (33)

1. Hristov M., Heussen N., Schober A., and Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 10 (2006) 727-733
2. Aicher A., Rentsch M., Sasaki K., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 100 (2007) 581-589
3. Heil M., Ziegelhoeffer T., Mees B., and Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res 94 (2004) 573-574
4. de Muinck E.D., and Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol 36 (2004) 25-32
5. Hickey M.M., and Simon M.C. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76 (2006) 217-257
6. Simon M.C., Liu L., Barnhart B.C., and Young R.M. Hypoxia-induced signaling in the cardiovascular system. Annu Rev Physiol 70 (2008) 51-71
7. Ceradini D.J., and Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15 (2005) 57-63
8. Majka M., Janowska-Wieczorek A., Ratajczak J., et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97 (2001) 3075-3085
9. Korff T., Kimmina S., Martiny-Baron G., and Augustin H.G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. Faseb J 15 (2001) 447-457
10. Kawamoto A., Iwasaki H., Kusano K., et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114 (2006) 2163-2169
11. Scheubel R.J., Kahrstedt S., Weber H., et al. Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes. Exp Gerontol 41 (2006) 540-548
12. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., and Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107 (2006) 2705-2712
13. Annabi B., Lee Y.T., Turcotte S., et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21 (2003) 337-347
14. Kidszun A., Schneider D., Erb D., et al. Isolated pancreatic islets in three-dimensional matrices are responsive to stimulators and inhibitors of angiogenesis. Cell Transplant 15 (2006) 489-497
15. Munk V.C., Sanchez de Miguel L., Petrimpol M., et al. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension 49 (2007) 1178-1185
16. Li T.S., Hamano K., Suzuki K., Ito H., Zempo N., and Matsuzaki M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283 (2002) H468-H473
17. O'Neill T.J., Wamhoff B.R., Owens G.K., and Skalak T.C. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97 (2005) 1027-1035
18. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
19. Tse H.F., Siu C.W., Zhu S.G., et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 9 (2007) 747-753
20. Li A., Varney M.L., Valasek J., Godfrey M., Dave B.J., and Singh R.K. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8 (2005) 63-71
21. Ogawa S., Yoshida S., Ono M., et al. Induction of macrophage inflammatory protein-1alpha and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis 3 (1999) 327-334
22. Caux C., Ait-Yahia S., Chemin K., et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22 (2000) 345-369
23. Nilsson M.B., Langley R.R., and Fidler I.J. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 65 (2005) 10794-10800
24. Hong K.H., Ryu J., and Han K.H. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105 (2005) 1405-1407
25. Vandervelde S., van Luyn M.J., Rozenbaum M.H., Petersen A.H., Tio R.A., and Harmsen M.C. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res 73 (2007) 783-793
26. Chen C.P., Lee Y.J., Chiu S.T., et al. The application of stem cells in the treatment of ischemic diseases. Histol Histopathol 21 (2006) 1209-1216
27. Sharma R., and Raghubir R. Stem cell therapy: a hope for dying hearts. Stem Cells Dev 16 (2007) 517-536
28. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 1-12
29. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
30. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
31. Laflamme M.A., Zbinden S., Epstein S.E., and Murry C.E. Cell-based therapy for myocardial ischemia and infarction:pathological mechanisms. Annu Rev Pathol Mech Dis 2 (2007) 307-339
32. Reffelmann T., Dow J.S., Dai W., Hale S.L., Simkhovich B.Z., and Kloner R.A. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol 35 (2003) 607-613
33. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150